Item 5.02 Departure of Directors or Certain Officers; Election of Directors;


          Appointment of Certain Officers; Compensatory Arrangements of Certain
          Officers.

Appointment of New Board Member

The Board of Directors of Assisted 4 Living, Inc. (the "Company") has created a new directorship and appointed David Verinder to the Board of Directors of the Company (the "Board"), effective September 23, 2021. Mr. Verinder will serve on the Board until his successor shall be duly elected and qualified, or until his earlier resignation or removal in accordance with the Company's Bylaws.

David Verinder, age 54, currently serves as the President & CEO of Sarasota Memorial Health Care System, a position he has held since 2014. During Mr. Verinder's tenure as CEO, Sarasota Memorial is the only hospital in Florida to earn the federal Centers for Medicare & Medicaid's highest 5-star rating for quality and safety in all reporting periods since the federal rating program began in 2016. Before assuming the CEO role, Mr. Verinder served as Sarasota Memorial's Chief Operating Officer starting in 2010, overseeing the health system's operations and ambulatory strategy. Mr. Verinder joined Sarasota Memorial in 2006 as Chief Financial Officer. As CFO, and continuing in his role as CEO, he successfully instituted significant financial and operational improvements, focusing on strategic growth opportunities, disciplined expense controls and improved financial results. Prior to joining Sarasota Memorial, Mr. Verinder served in senior leadership positions at Scott & White Memorial Hospital & Clinic in Temple, Texas. Mr. Verinder earned a Bachelor of Science degree from Louisiana State University, and a Master of Business Administration degree from Auburn University. Florida Trend magazine included Mr. Verinder on its list of Florida's 500 most influential business leaders in 2018, 2019 and 2020.

Neither Mr. Verinder, nor any member of his immediate family, has, to the knowledge of the Company, had a material interest, direct or indirect, since the beginning of the Company's last fiscal year, in any transaction or proposed transaction which may materially affect the Company.

© Edgar Online, source Glimpses